BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25324955)

  • 1. Role of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a review.
    Mewawalla P; Nathan S
    Ther Adv Hematol; 2014 Oct; 5(5):139-52. PubMed ID: 25324955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia.
    Dreger P; Montserrat E
    Leukemia; 2002 Jun; 16(6):985-92. PubMed ID: 12040430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic transplantation for chronic lymphocytic leukemia.
    Laurenti L; Tarnani M; Chiusolo P; Sorà F; Sica S
    Mediterr J Hematol Infect Dis; 2010 Sep; 2(2):e2010026. PubMed ID: 21415973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.
    Machaczka M; Johansson JE; Remberger M; Hallböök H; Lazarevic VLj; Wahlin BE; Omar H; Wahlin A; Juliusson G; Kimby E; Hägglund H
    Med Oncol; 2013 Dec; 30(4):762. PubMed ID: 24214180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
    Iovino L; Shadman M
    Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for the next decade: allogeneic stem cell transplantation in chronic lymphocytic leukemia.
    Corradini P; Farina L
    Leuk Suppl; 2012 Aug; 1(Suppl 2):S33-4. PubMed ID: 27175243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How and when I do allogeneic transplant in CLL.
    Gribben JG
    Blood; 2018 Jul; 132(1):31-39. PubMed ID: 29752258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
    Hill BT; Ahn KW; Hu ZH; Aljurf M; Beitinjaneh A; Cahn JY; Cerny J; Kharfan-Dabaja MA; Ganguly S; Ghosh N; Grunwald MR; Inamoto Y; Kindwall-Keller T; Nishihori T; Olsson RF; Saad A; Seftel M; Seo S; Szer J; Tallman M; Ustun C; Wiernik PH; Maziarz RT; Kalaycio M; Alyea E; Popat U; Sobecks R; Saber W
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):581-586. PubMed ID: 29032274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.
    Dreger P; Corradini P; Kimby E; Michallet M; Milligan D; Schetelig J; Wiktor-Jedrzejczak W; Niederwieser D; Hallek M; Montserrat E;
    Leukemia; 2007 Jan; 21(1):12-7. PubMed ID: 17109028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant in chronic lymphocytic leukemia: to do it or not and if so, when and how?
    Gribben JG
    Am Soc Clin Oncol Educ Book; 2012; ():399-404. PubMed ID: 24451771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens.
    Kharfan-Dabaja MA; Bazarbachi A
    Cancer Control; 2012 Jan; 19(1):68-75. PubMed ID: 22143063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
    Dreger P; Michallet M; Schmitz N
    Ann Oncol; 2000; 11 Suppl 1():49-53. PubMed ID: 10707779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
    Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
    Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
    Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.
    Giné E; Moreno C; Esteve J; Montserrat E
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell transplantation in chronic lymphocytic leukemia.
    Gribben JG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):53-8. PubMed ID: 19147079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients.
    Greiner J; Götz M; Bunjes D; Hofmann S; Wais V
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31878060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality--a single institution experience.
    Chakupurakal G; Leitzke S; Langerbeins P; Schiller J; Schneider PM; Holtick U; Shimabukuro-Vornhagen A; Theurich S; Chemnitz J; Hallek M; von Bergwelt-Baildon M; Scheid C
    Ann Hematol; 2015 Oct; 94(10):1717-25. PubMed ID: 26259502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemia.
    Jaglowski SM; Byrd JC
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S132-8. PubMed ID: 22226097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.